Disclosure statement
T.H. – no relevant conflict of interest; L.S. – no relevant conflict of interest; D.Z. serves as a consultant for Novartis, Bristol Myers Squibb, Angelini and Incyte; B.W. – no relevant conflict of interest; Z.S. – no relevant conflict of interest; J.P. declares no relevant conflict of interest; P.B. – no relevant conflict of interest; L.S. – no relevant conflict of interest, P.R. – serves/d as a consultant for Novartis; Z.R. received research funding from Novartis, Bristol Mayer Squibb and serves on a speakers bureau for Novartis and Bristol Myers Squibb; J.M. received research funding from Novartis, Angelini, Bristol Mayer Squibb and serves on a speakers bureau for Novartis and Bristol Myers Squibb.